Abstract: HLA-A2 molecules with naturally occurring single amino acid substitutions of
Phe to Tyr at position 9 (HLA-A2.4a, Tyr9) and
Tyr to Cys at position 99 (HLA-A2.4b, Cys99) and a site directed mutant with a
Val to Leu substitution at position 95 (Leu95) were examined for their ability to present the influenza virus
matrix M1 55-73 peptide and several sequence variants of the
M1 peptide to a panel of 36
M1 55-73-specific HLA-A2.1-restricted CTL lines.